Cencora Inc.
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Cencora Inc. (COR). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| U.S. Healthcare Solutions | $202.46B 94.6% | $212.10B 88.9% · +4.8% | $234.76B 89.5% · +10.7% | $265.34B 90.3% · +13.0% | $290.98B 90.6% · +9.7% |
| International Healthcare Solutions | $11.53B 5.4% | $26.49B 11.1% · +129.8% | $27.42B 10.5% · +3.5% | $28.63B 9.7% · +4.4% | $30.37B 9.4% · +6.1% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| U.S. Healthcare Solutions | $2.26B 1.1% | $2.46B 1.2% | $2.60B 1.1% | $2.93B 1.1% | $3.57B 1.2% |
| International Healthcare Solutions | $390.3M 3.4% | $706.5M 2.7% | $692.6M 2.5% | $713.4M 2.5% | $648.3M 2.1% |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.